Thursday, July 26, 2012

HALO, BREVAGen and density!

These are the three important words for 90% of the women who don't want to wait for breast cancer.  Two noninvasive tests and one mammographic finding give us a clearer picture of a woman's individual risk for breast cancer.


The HALO Breast Pap Test (http://www.halohc.com/halonaf/NAF-Collection.aspx) is routine breast health monitor of cellular changes that may happen in the breast ducts long before the cancer appears.  Fluid from the nipple is obtained by an office procedure that is safe, noninvasive, takes only 5 minutes and is especially useful for women between 21 and 35 years. The result tells us who is at higher risk for developing cancer in the nest 8 years allowing us to intervene before cancer happens.



The BREVAGen Breast Cancer Risk Assessment (
http://brevagen.com/homeis a one-time, noninvasive office procedure.   A woman's genetic information from a cheek swab is combined with clinical data to arrive at a personalized 5 year and lifetime risk for breast cancer.  It is an ideal study for women from 35 to 64 years.  



The mammogram report includes the density of the breast tissue and studies have demonstrated that breast cancer develops 5x more often in dense breasts than in the least dense breasts as judged by mammography.



These three words should be important to any woman who wants to know more about her own risk for breast cancer.  In future blogs we will discuss the options, given the results, for a personalized breast health plan. 





Together we can prevent 75,000 breast cancer cases each year!




Remember that this blog content is general information and not personal medical advice, so ask your doctor how each may help you.

No comments:

Post a Comment